Delivery Order SPE2DB22D3016-SPE2DB24FAUA7
Award Date 4/30/24
Potential Completion Date 5/1/24
Potential Value $5.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,235.55 delivery order is for the supply of 4 mg Ondansetron ODT tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of April 18, 2023 and is a firm fixed-price delivery order under the DLA's Indefinite Delivery Contract (IDC) with Cencora, Inc. valued at up to $999,999,999.00. This IDC serves as the...
- This federal contract award, valued at $1,855.62, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,590,528 tablets of Ondansetron HCL 4 mg, a generic pharmaceutical product used to treat nausea and vomiting. The contract is a Delivery Order placed under an existing Indefinite Delivery Contract (IDC) between the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for 4,560,886,465 units of Ondansetron HCL 4 mg tablets. The $20,262.06 firm-fixed-price contract has a completion date of May 11, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as the...
- This federal contract award, valued at $4,615.81, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,586,918 units of Ondansetron HCL 8 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 25, 2023. It is not designated as a set-aside contract. Amerisourcebergen...
- This federal contract award with ID SPE2DB22D3009|SPE2DB24FAH96 was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,562,765,658 units of the medication Ondansetron HCL 4 mg Tablet, with a total ceiling value of $7,240.60. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. The award is part of a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,785,987 units of the medication Ondansetron HCL 8 mg tablets. The contract has a ceiling value of $2,998.85 and a completion date of February 1, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,004,123 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $15,568.87 and a completion date of December 6, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $56,685.70 firm-fixed-price delivery order is for the supply of 500 units of Ondansetron HCL 4 mg tablets. The award has an ultimate completion date of February 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...
- This federal contract award, valued at $12,457.19, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,179 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- The U.S. government's Defense Logistics Agency (DLA) awarded a Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Ondansetron HCL 4 mg tablets. The contract, valued at $1,590.86, is a Firm Fixed Price agreement with a completion date of May 3, 2023. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The...